Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults. (Q40350571)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 August 2010

Language	Label	Description	Also known as
English	Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults.	scientific article published on 21 August 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

yellow fever virus

0 references

1 reference

based on heuristic

inferred from title

Denise Silveira Lemos

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Silvana Maria Elói-Santos

10

object named as

Silvana Maria Elói-Santos

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Andréa Teixeira de Carvalho

9

object named as

Andréa Teixeira-Carvalho

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Maria Luiza Silva

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Marina Angela Martins

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Luçandra Ramos Espírito-Santo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ana Carolina Campi-Azevedo

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

José Geraldo Leite Ribeiro

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Akira Homma

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Olindo Assis Martins-Filho

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

0 references

publication date

21 August 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

583-592

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

The global resurgence of arboviral diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Yellow fever: the recurring plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

The use of yellow fever virus modified by in vitro cultivation for human immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

New developments in flavivirus vaccines with special attention to yellow fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Detection of Th1/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

TLR expression and NK cell activation after human yellow fever vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Immune response during adverse events after 17D-derived yellow fever vaccination in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania c

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Yellow fever vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Men with low vitamin A stores respond adequately to primary yellow fever and secondary tetanus toxoid vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

The role of helper T cell products in mouse B cell differentiation and isotype regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Molecular regulation of B lymphocyte response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: a study with allergen-specific human helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Cytokines and migraine: increase of IL-5 and IL-4 plasma levels.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.046

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.08.046

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732465%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40350571&oldid=1905631268"